SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Hahn TJ, Hendin BA, Scharp CR, et al. Serum 25-hydroxycholecalciferol levels and bone mass in children on chronic anticonvulsant therapy. N Engl J Med 1976;292: 5504.
  • 2
    Fischer MH, Adkins WN Jr, Liebl BH, et al. Bone status in non-ambulant, epileptic, institutionalized youth. Clin Pediatr 1988;10: 499505.
  • 3
    Akin R, Okutan V, Sarici Ü, et al. Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr Neurol 1998;19: 12931.
  • 4
    Välimäki MJ, Tiihonen M, Laitinen K, et al. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J Bone Miner Res 1994;9: 6317.
  • 5
    Kruse K, Suss A, Busse M, et al. Monomeric serum calcitonin and bone turnover during anticonvulsant treatment and in congenital hypothyroidism. J Pediatr 1987;111: 5763.
  • 6
    Melkko J, Niemi S, Risteli L, et al. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 1990;36: 132832.
  • 7
    Melkko J, Kauppila S, Niemi F, et al. Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin Chem 1996;42: 94754.
  • 8
    Kikuchi T, Hashimoto N, Kawasaki T, et al. Plasma levels of carboxy-terminal propeptide of type I procollagen and pyridinoline cross-linked telopeptide of type I collagen in healthy school children. Acta Paediatr 1998;87: 8259.
  • 9
    Tanner JM. Physical growth and development. In: ForfarJO, ArnellCC, eds. Textbook of pediatrics. 2nd ed. Edinburgh: Churchill Livingstone, 1978: 249303.
  • 10
    Cacciari E, Milani S, Balsamo A, et al. Italian cross-sectional growth charts for height, weight and BMI. Eur J Clin Nutr 2002;56: 17180.
  • 11
    Verrotti A, Basciani F, Carle F, et al. Calcium metabolism in adolescents and young adults with type 1 diabetes mellitus without and with persistent microalbuminuria. J Endocrinol Invest 1999;22: 198202.
  • 12
    Berry EM, Gupta MM, Turner SJ, et al. Variations in plasma calcium with induced changes in plasma specific gravity, total protein and albumin. Br Med J 1973;4: 6405.
  • 13
    Verrotti A, Basciani F, Carle F, et al. Calcium metabolism in adolescents and young adults with type 1 diabetes mellitus without and with persistent microalbuminuria. J Endocrinol Invest 1999;22: 198202.
  • 14
    Takeshita N, Seino Y, Ishida H, et al. Increased circulating levels of γ-carboxyglutamic acid-containing protein and decreased bone mass in children on anticonvulsant therapy. Calcif Tissue Int 1989;44: 805.
  • 15
    Eyre DR, Gertz BJ, Shao P, et al. Monitoring bone resorption in early post-menopausal women by an immunoassay for cross-linked collagen peptides. J Bone Miner Res 1992;7: S143.
  • 16
    Eriksen EF, Charles P, Melsen F, et al. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res 1993;8: 12732.
  • 17
    Tjellesen L, Nilas L, Christiansen C. Does carbamazepine cause disturbances in calcium metabolism in epileptic patients? Acta Neurol Scand 1983;68: 139.
  • 18
    Weinstein RS, Bryce GF, Sappington LJ, et al. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment. J Clin Endocrinol Metab 1984;58: 10039.